Jeffrey H Rodenberg

US Patent:

8323658, Dec 4, 2012

Filed:

Oct 28, 2010

Appl. No.:

12/914591

Inventors:

Jeffrey Harold Rodenberg - Fort Dodge IA, US
Mahesh Kumar - Fort Dodge IA, US
Kalen Cookson - Lawrenceville GA, US

Assignee:

PAH W LLC - New York NY

International Classification:

A61K 39/12
A61K 39/295
C07K 14/08
C12N 7/00

US Classification:

4241861, 4242041, 4242021, 530350, 4352351

Abstract:

Antigenic isolates and vaccines for Infectious Bursal Disease Virus include variants of the molecular Group 6 family of IBDV isolates, in particular the 28-1 isolate.

US Patent:

20050266019, Dec 1, 2005

Filed:

Mar 10, 2005

Appl. No.:

11/076713

Inventors:

Jeffrey Rodenberg - Fort Dodge IA, US
Mahesh Kumar - Fort Dodge IA, US
Kalen Cookson - Lawrenceville GA, US

Assignee:

Wyeth - Madison NJ

International Classification:

A61K039/12
C07K014/005

US Classification:

424199100, 530350000

Abstract:

Antigenic isolates and vaccines for Infectious Bursal Disease Virus include variants of the molecular Group 6 family of IBDV isolates, in particular the 28-1 isolate.

US Patent:

20080193480, Aug 14, 2008

Filed:

Jun 8, 2007

Appl. No.:

11/811222

Inventors:

Jeffrey Harold Rodenberg - Fort Dodge IA, US
Mahesh Kumar - Fort Dodge IA, US
Kalen Cookson - Lawrenceville GA, US

Assignee:

Wyeth - Madison NJ

International Classification:

A61K 39/12
A61P 31/14

US Classification:

4242041

Abstract:

Antigenic isolates and vaccines for Infectious Bursal Disease Virus include variants of the molecular Group 6 family of IBDV isolates, in particular the 28-1 isolate.

US Patent:

20090017067, Jan 15, 2009

Filed:

Jun 19, 2008

Appl. No.:

12/142160

Inventors:

Evan James Diehl - Iowa City IA, US
David Leon Lutz - Harcourt IA, US
Jeffrey Harold Rodenberg - Fort Dodge IA, US
Mahesh Kumar - Fort Dodge IA, US

Assignee:

Wyeth - Madison NJ

International Classification:

A61K 39/00
A61K 39/12
A61K 39/02
A61K 39/145

US Classification:

4242091, 4241841, 4242041, 4242341, 4242741

Abstract:

Emulsion vaccine formulations containing an antigen and an adjuvant in the aqueous phase are used for the vaccination of animals wherein the adjuvant is an acrylic polymer and/or dimethyl dioctadecyl ammonium bromide (DDA). These formulations can be prepared by mixing an aqueous phase containing the antigen and adjuvant with an oil phase in the presence of an emulsifier.

US Patent:

20150297710, Oct 22, 2015

Filed:

Feb 10, 2015

Appl. No.:

14/618628

Inventors:

- Florham Park NJ, US
David Leon Lutz - Harcourt IA, US
Jeffrey Harold Rodenberg - Kalamazoo MI, US
Mahesh Kumar - Kalamazoo MI, US

International Classification:

A61K 39/145
A61K 9/107
C12N 7/00

Abstract:

Emulsion vaccine formulations containing an antigen and an adjuvant in the aqueous phase are used for the vaccination of animals wherein the adjuvant is an acrylic polymer and/or dimethyl dioctadecyl ammonium bromide (DDA). These formulations can be prepared by mixing an aqueous phase containing the antigen and adjuvant with an oil phase in the presence of an emulsifier.